Results 161 to 170 of about 15,511 (270)

Corrigendum to “Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women” [Contraception 99 (2019) 199–204]

, 2019
Renee Heffron, Sharon L. Achilles, Laneta J. Dorflinger, Janet P. Hapgood, James Kiarie, Chelsea B. Polis, Petrus S. Steyn   +6 more
openalex   +2 more sources

THE RELATIONSHIP OF THE USE OF 3 MONTHS DMPA INJECTING CONTRACEPTION WITH MATERNAL WEIGHT INCREASE AT BAUMATA PUBLIC HEALTH CENTER

, 2021
Siti Nur Asyah Jamillah Ahmad Nur, Dina M.S Henukh, Frida S Pay   +2 more
openalex   +2 more sources

The prominent factors of the selection of injecting contraception equipment in women of childbearing age in Yogyakarta [PDF]

, 2021
Nur Azizah Indriastuti, Riski Oktafia, Agista Wulan Aviani   +2 more
openalex   +1 more source

Working with historicity: tracing shifts in contraceptive use in the activity system of sex over time

Psychology in Society, 2012
Sexual activity, sexuality and responses to HIV and AIDS in a rural context in South Africa were studied using a cultural-historical activity theory framework. Activity theory directs the focus onto activity and emphasises the importance of an historical
Mary van der Riet
doaj  

Pattern and Predictors of Post-partum Contraception in a Slum Population of a District of Odisha, India: A Cross Sectional Study

Preventive Medicine: Research & Reviews
Objective: To assess the prevalence, pattern and predictors of post-partum contraceptive use amongst married women in a slum population of Cuttack, Odisha, India.
Debjyoti Mohapatra, Saffalya Nayak, Santanu K Padhy   +2 more
doaj   +1 more source

Counseling on injectable contraception and HIV risk: Evaluation of a pilot intervention in Tanzania. [PDF]

PLoS One, 2020
Barden-O'Fallon J, Mason J, Tluway E, Kwesigabo G, Kamanyi E.   +4 more
europepmc   +1 more source

THE MOTHER’S MENSTRUAL CYCLE DIFFERENT BETWEEN MOTHER WHO USE IUD CUT-380A CONTRACEPTION WITH A 3 MOUNTH INJECTABLE CONTRACEPTIVE DEPO VIGESTRON IN MUNJUL VILLAGE PANDEGLANG DISTRIC OF BANTEN 2014.

, 2014
Mala Kurniati, Deviani Utami
openalex   +2 more sources

Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk – Authors' reply [PDF]

, 2015
Heidi E. Jones, Janneke van de Wijgert
openalex   +3 more sources

What are the relative risks and benefits of progestin-only contraceptives? [PDF]

, 2005
Little evidence describes the risks and benefits of progestin-only contraceptives therapy. No good-quality evidence exists to determine the risk of cancer associated with progestin-only contraceptives.
Blackwell, Jean, Roederer, Mary W.
core  

Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa [PDF]

, 2021
Lisa Noguchi, Jeanne Marrazzo, Barbara D. Richardson, Sharon L. Hillier, Jennifer E. Balkus, Thesla Palanee‐Phillips, Gonasagrie Nair, Ravindre Panchia, Jeanna Piper, Kailazarid Gomez, Gita Ramjee, Zvavahera M. Chirenje   +11 more
openalex   +1 more source